Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Group 1 - Standard BioTools Inc. will publish its third quarter 2025 financial results on November 4, 2025, after U.S. market close [1] - The company is a leading provider of next-generation technologies that assist biomedical researchers in developing better medicines more efficiently [2] - Standard BioTools utilizes proprietary technologies such as SomaScan, mass cytometry, and microfluidics to provide insights in health and disease [2] Group 2 - The company collaborates with various sectors including academic, government, pharmaceutical, and biotechnology laboratories globally [2] - Focus areas for Standard BioTools include translational and clinical research, particularly in oncology, immunology, and immunotherapy [2]